Crinetics Pharmaceuticals, Inc.
$36.77
USD
Last updated on --.
24h volume716.51K
24h highest37.3637 USD
24h lowest36.4300 USD
24h Price movement-0.08%
CRNX recent prices
24 Hours
-0.08%-$0.03
30 days
-4.71%-$1.820
60 days
+9.30%+$3.130
90 days
-15.19%-$6.590
Key data
Previous close36.8000 USD
Market cap3.82B USD
Volume716.51K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-4.7100 USD
Net income (FY)-496.39M USD
Revenue (FY)18.07M USD
Last report date7 May 2026
About Crinetics Pharmaceuticals, Inc.
HeadquartersSAN DIEGO
Employees (FY)594.00
Revenue per employee (FY)30.42K USD
Net income per employee (FY)-835.67K USD
Listed onNasdaq
CRNX conversion tables
 |  |
|---|---|
| 0.5 CRNX | 18.38 USD |
| 1 CRNX | 36.77 USD |
| 5 CRNX | 183.85 USD |
| 10 CRNX | 367.7 USD |
| |
|---|---|
| 0.5 USD | 0.013598 CRNX |
| 1 USD | 0.027196 CRNX |
| 5 USD | 0.13598 CRNX |
| 10 USD | 0.27196 CRNX |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CRNX is trading at $36.77, -0.08% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CRNX stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CRNX is currently trading at $36.77, -0.08% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CRNX price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CRNX's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CRNX; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CRNX's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Crinetics Pharmaceuticals, Inc.'s market cap is currently 3.82B USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume716.51K
24h highest37.3637 USD
24h lowest36.4300 USD
24h Price movement-0.08%
Start trade with CRNX Perpetual
Sign up to trade